Filer Snapshot

Eric Venker

CIK 0001801917. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

11

Latest filing

23 Jan 2024

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for ROIV. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 23 Jan 2024 for CIK 0001801917.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

Forms 3/4/5 positions$177.95M

Reporting-owner positions with enough filing detail to estimate value.

Forms 3/4/5 position value

3/4/5
$177.95M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

ROIV IMVT
How to read these SEC ownership signals
  • Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
  • Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
C/O Roivant Sciences, Inc., 7 Th Floor, 50 Broadway, London, SW1H 0DB

Filer intelligence

What SEC filings say about Eric Venker

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for ROIV worth $171.69M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

ROIV

20 May 2026 · President & Immunovant CEO

$171.69M

IMVT

07 Apr 2026 · Chief Executive Officer

$6.25M

Latest update

What changed recently for Eric Venker

Ownership report updated

Latest ownership report period: 20 May 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

22 May 2026

Page type

Ownership filings

Latest period

20 May 2026

Ownership context was refreshed from SEC Forms 3/4/5 filed on 22 May 2026.

SEC filing record

CIK 0001801917 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
11
First seen
16 Aug 2023
Latest filing
23 Jan 2024
Entity
Individual

Observed form types

4

Latest Filings

Showing the latest 11 of 11 SEC filings for Eric Venker.

4

4 filing

Filing date
23 Jan 2024
Reporting date
20 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Nov 2023
Reporting date
22 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Oct 2023
Reporting date
24 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2023
Reporting date
02 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Sep 2023
Reporting date
27 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Sep 2023
Reporting date
22 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Sep 2023
Reporting date
08 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2023
Reporting date
04 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Aug 2023
Reporting date
22 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Aug 2023
Reporting date
14 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .